S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q1 2023

BVF Partners

Period: Q1 2023 Β· Filed: 2023-05-15
View on SEC EDGAR β†—
AUM
$2.74B
Total portfolio value
Positions
72
Reported securities
Top Holding
MLTX
17.0% $465.3M
QoQ Changes
+4 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$465.3M17.01%$21.39$18.95-11.4%
17.0%
KYMRKYMERA THERAPEUTICS INC$140.4M5.13%$29.63$113.51+283.1%
5.1%
AXSMAXSOME THERAPEUTICS INC$131.4M4.81%$61.68$244.31+296.1%
4.8%
RVMDREVOLUTION MEDICINES INC$107.3M3.92%$21.66$189.24+773.7%
3.9%
IONSIONIS PHARMACEUTICALS INC$91.5M3.35%$35.74$81.80+128.9%
3.4%
PTGXPROTAGONIST THERAPEUTICS INC$86.8M3.17%$23.00$131.62+472.3%
3.2%
LKFTGALAPAGOS NV$83.7M3.06%$38.64$30.39-21.4%
3.1%
KURAKURA ONCOLOGY INC$82.3M3.01%$12.23$11.10-9.2%
3.0%
RPTXREPARE THERAPEUTICS INC$81.6M2.98%β€”β€”
3.0%
PNTPOINT BIOPHARMA GLOBAL INC$76.8M2.81%β€”β€”
2.8%
XOMAXOMA CORP DEL$76.7M2.80%$21.11$43.00+103.7%
2.8%
GHRSGH RESEARCH PLC$74.1M2.71%$7.99$27.01+238.1%
2.7%
FDMT4D MOLECULAR THERAPEUTICS IN$68.9M2.52%$17.19$13.00-24.4%
2.5%
XENEXENON PHARMACEUTICALS INC$65.4M2.39%$35.79$60.96+70.3%
2.4%
MRUSMERUS N V$54.8M2.00%β€”β€”
2.0%
ZYMEZYMEWORKS INC$53.1M1.94%$9.04$26.31+191.0%
1.9%
TYRATYRA BIOSCIENCES INC$52.1M1.90%$16.07$30.62+90.5%
1.9%
RLAYRELAY THERAPEUTICS INC$51.4M1.88%$16.47$18.65+13.2%
1.9%
SNDXSYNDAX PHARMACEUTICALS INC$45.3M1.65%$21.12$21.82+3.3%
1.6%
CRNXCRINETICS PHARMACEUTICALS IN$44.0M1.61%$16.06$42.23+162.9%
1.6%
GPCRSTRUCTURE THERAPEUTICS INC$41.6M1.52%$23.79$53.45+124.7%
1.5%
IMVTIMMUNOVANT INC$39.7M1.45%$15.51$38.79+150.1%
1.4%
LXRXLEXICON PHARMACEUTICALS INC$39.2M1.43%$2.43$2.32-4.5%
1.4%
REPLREPLIMUNE GROUP INC$37.9M1.38%$17.66$11.58-34.4%
1.4%
CTICCTI BIOPHARMA CORP$37.0M1.35%β€”β€”
1.4%
CNTACENTESSA PHARMACEUTICALS PLC$36.3M1.33%$3.85$40.50+952.0%
1.3%
IDYAIDEAYA BIOSCIENCES INC$33.7M1.23%$13.73$37.65+174.2%
1.2%
CGEMCULLINAN ONCOLOGY INC$32.7M1.20%$10.23$17.63+72.3%
1.2%
RAINRAIN ONCOLOGY INC$30.8M1.13%β€”$1.97
1.1%
ETNB89BIO INC$28.1M1.03%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q1 2023 vs. Q4 2022

New Positions (4)

TickerIssuerNotionalSince Filing
PTGXPROTAGONIST THERAPEUTICS INC$86.8M+472.3%
GPCRSTRUCTURE THERAPEUTICS INC$41.6M+124.7%
ETNB89BIO INC$28.1M
JSPRXXXXJASPER THERAPEUTICS INC$17.9M

Exited Positions (8)

TickerIssuerNotional
RCUSARCUS BIOSCIENCES INC$47.6M
CNCECONCERT PHARMACEUTICALS INC$21.2M
ANNXANNEXON INC$19.6M
COGTCOGENT BIOSCIENCES INC$11.4M
PYXSPYXIS ONCOLOGY INC$3.9M
RNACSELECTA BIOSCIENCES INC$1.6M
CALACALITHERA BIOSCIENCES INC$1.5M
XFORXXXXX4 PHARMACEUTICALS INC$1.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
LKFTGALAPAGOS NV$79.2M+2065.1%-21.4%
IONSIONIS PHARMACEUTICALS INC$49.1M+128.3%+128.9%
KURAKURA ONCOLOGY INC$35.1M+77.1%-9.2%
RVMDREVOLUTION MEDICINES INC$29.8M+52.2%+773.7%
SNDXSYNDAX PHARMACEUTICALS INC$8.3M+47.7%+3.3%
XENEXENON PHARMACEUTICALS INC$15.3M+43.8%+70.3%
REPLREPLIMUNE GROUP INC$-3.6M+40.7%-34.4%
CNTACENTESSA PHARMACEUTICALS PLC$14.9M+36.7%+952.0%

Trimmed (6)

TickerIssuerNotionalShares Ξ”Since Filing
VRDNVIRIDIAN THERAPEUTICS INC$-31.9M-86.4%
CGEMCULLINAN ONCOLOGY INC$-46.5M-57.4%+72.3%
WHWKAADI BIOSCIENCE INC$-4.9M-43.4%
ALPNALPINE IMMUNE SCIENCES INC$-1.7M-24.4%
GLMDGALMED PHARMACEUTICALS LTD$-0.3M-22.5%
RLAYRELAY THERAPEUTICS INC$-6.5M-19.5%+13.2%
← Back to Hedge Funds